News
Article
Author(s):
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Facial hyperpigmentation may signal systemic disease. Dermatologists must assess beyond melasma to ensure timely, accurate diagnosis and care.
In a large study, nearly half of SIND patients also had other BFRBs like skin picking or hair pulling.
Evommune has initiated a global phase 2b trial of EVO756, a first-in-class MRGPRX2 antagonist, for moderate to severe CSU.
The funds will target programs for chronic pruritus, atopic dermatitis, and other inflammatory skin conditions.
Corticosteroids, calcineurin inhibitors, and fractional CO2 laser were also effective in achieving high levels of repigmentation.
Phototherapy, commonly used for vitiligo, might help reduce cardiovascular risk through anti-inflammatory effects.
Improvements in hydration, erythema, itching, and burning were observed after 12 weeks of treatment for papulopustular rosacea.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.